A detailed history of Rocky Mountain Advisers, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rocky Mountain Advisers, LLC holds 2,267 shares of MRK stock, worth $224,841. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,267
Previous 2,267 -0.0%
Holding current value
$224,841
Previous $280,000 8.21%
% of portfolio
0.21%
Previous 0.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 26, 2019

SELL
$69.84 - $81.59 $6,145 - $7,179
-88 Reduced 3.74%
2,267 $190,000
Q3 2018

Oct 23, 2018

BUY
$57.69 - $67.84 $3,288 - $3,866
57 Added 2.48%
2,355 $167,000
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $4,473 - $5,255
88 Added 3.98%
2,298 $139,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,210
2,210 $142,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Rocky Mountain Advisers, LLC Portfolio

Follow Rocky Mountain Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rocky Mountain Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rocky Mountain Advisers, LLC with notifications on news.